LeMaitre Vascular, Inc. LMAT
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -0.20%
- 1 year
- -8.59%
- Open
- 85.53
- Prev close
- 85.27
- Mkt cap
- 1.85B
- Vol
- 427.37K
- Avg vol
- 326.05K
- EPS
- 2.85
- P/E
- 28.40
- Div yield
- 1.17%
More statistics
- Low
- 80.03
- High
- 85.53
- Forward P/E
- 25.46
- Beta
- 0.47
- Short ratio
- 6.66
- Inst. own
- 104.08%
- Dividend
- 1.00
- Ex-div date
- Aug 19, 2026
- Earnings
- Nov 4, 2026
- 50-d avg
- 81.23
- 200-d avg
- 94.49
- 1y target
- 107.00
2Y chart
Events in this range
- Nov 21, 2024Dividend: 0.16
- Mar 13, 2025Dividend: 0.2
- May 15, 2025Dividend: 0.2
- Aug 5, 2025Earnings: 0.6; estimate 0.57; surprise 5.26%
- Aug 21, 2025Dividend: 0.2
- Nov 6, 2025Earnings: 0.62; estimate 0.564; surprise 9.93%
- Nov 20, 2025Dividend: 0.2
- Feb 25, 2026Earnings: 0.68; estimate 0.67; surprise 1.49%
- Feb 26, 2026Rating: Barrington Research · Outperform → Outperform
- Mar 12, 2026Dividend: 0.25
- May 5, 2026Earnings: 0.68; estimate 0.66; surprise 3.03%
- May 6, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- May 6, 2026Rating: Citizens · Market Outperform → Market Outperform
- May 6, 2026Rating: Barrington Research · Outperform → Outperform
- May 21, 2026Dividend: 0.25
- Jun 3, 2026Rating: Barrington Research · Outperform → Outperform
- Aug 4, 2026Earnings: 0.74; estimate 0.807; surprise -8.3%
- Aug 5, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Aug 20, 2026Dividend: 0.25
Signals (106)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 2 days ago |
| SMA: Bullish | Oct 19, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 12, 2026 | 2 weeks ago |
| MACD: Buy Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 5, 2026 | 2 months ago |
| RSI: Oversold | Aug 5, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 29, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 15, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| SMA: Bearish | Jun 10, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 8, 2026 | 4 months ago |
| SMA: Bullish | Jun 5, 2026 | 4 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| RSI: Oversold | Jun 1, 2026 | 5 months ago |
| RSI: Oversold | May 12, 2026 | 5 months ago |
| SMA: Bearish | May 7, 2026 | 5 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 16, 2026 | 6 months ago |
| RSI: Overbought | Apr 14, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 19, 2026 | 7 months ago |
| RSI: Overbought | Mar 17, 2026 | 7 months ago |
| RSI: Overbought | Mar 6, 2026 | 8 months ago |
| RSI: Overbought | Feb 26, 2026 | 8 months ago |
| RSI: Overbought | Feb 20, 2026 | 8 months ago |
| SMA: Bullish | Feb 3, 2026 | 9 months ago |
| MACD: Buy Signal | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 30, 2026 | 9 months ago |
| SMA: Bearish | Jan 29, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 29, 2026 | 9 months ago |
| SMA: Bullish | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 23, 2026 | 9 months ago |
| SMA: Bearish | Jan 22, 2026 | 9 months ago |
| SMA: Bullish | Jan 21, 2026 | 9 months ago |
| SMA: Bearish | Jan 20, 2026 | 9 months ago |
| SMA: Bullish | Jan 15, 2026 | 9 months ago |
| SMA: Bullish | Jan 14, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 31, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 12, 2025 | 10 months ago |
| SMA: Bearish | Nov 24, 2025 | 11 months ago |
| SMA: Bullish | Nov 21, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 18, 2025 | 11 months ago |
| SMA: Bearish | Nov 17, 2025 | 11 months ago |
| SMA: Bearish | Nov 14, 2025 | 11 months ago |
| SMA: Bullish | Nov 11, 2025 | 11 months ago |
| SMA: Bullish | Nov 11, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 11, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 4, 2025 | 12 months ago |
| SMA: Bearish | Oct 31, 2025 | 1 year ago |
| SMA: Bullish | Oct 21, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 14, 2025 | 1 year ago |
| RSI: Oversold | Sep 25, 2025 | 1 year ago |
| SMA: Bearish | Sep 24, 2025 | 1 year ago |
| SMA: Bearish | Sep 23, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 27, 2025 | 1 year ago |
| RSI: Overbought | Aug 12, 2025 | 1 year ago |
| RSI: Overbought | Aug 6, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 4, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 30, 2025 | 1 year ago |
| SMA: Bearish | Jul 15, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| SMA: Bullish | Jul 8, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jul 2, 2025 | 1 year ago |
| SMA: Bearish | Jun 26, 2025 | 1 year ago |
| SMA: Bullish | Jun 24, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 23, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 17, 2025 | 1 year ago |
| SMA: Bearish | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | Jun 6, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 3, 2025 | 1 year ago |
| MACD: Sell Signal | May 22, 2025 | 1 year ago |
| SMA: Bearish | May 21, 2025 | 1 year ago |
| MACD: Buy Signal | May 19, 2025 | 1 year ago |
| SMA: Bullish | May 16, 2025 | 1 year ago |
| SMA: Bearish | May 2, 2025 | 1 year ago |
| MACD: Sell Signal | May 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 23, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 8, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 20, 2025 | 1 year ago |
| RSI: Oversold | Mar 6, 2025 | 1 year ago |
| SMA: Bearish | Feb 28, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 28, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 18, 2025 | 1 year ago |
| SMA: Bullish | Feb 13, 2025 | 1 year ago |
| SMA: Bearish | Feb 11, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 11, 2025 | 1 year ago |
| SMA: Bullish | Feb 5, 2025 | 1 year ago |
| SMA: Bearish | Jan 31, 2025 | 1 year ago |
| SMA: Bullish | Jan 27, 2025 | 1 year ago |
| SMA: Bearish | Jan 22, 2025 | 1 year ago |
| SMA: Bullish | Jan 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 7, 2025 | 1 year ago |
Key statistics
- Market cap
- 1.85B
- Enterprise value
- 1.76B
- Trailing P/E
- 28.40
- Forward P/E
- 25.46
- PEG ratio
- 2.26
- Price / sales
- 7.05
- Price / book
- 4.40
- EPS (TTM)
- 2.85
- Beta
- 0.47
- Dividend yield
- 1.17%
- Payout ratio
- 31.58%
- Profit margin
- 25.02%
- Revenue (TTM)
- 262.43M
- Revenue growth
- 9.60%
- Free cash flow
- 49.26M
- Total cash
- 376.24M
- Total debt
- 190.25M
- Return on equity
- 16.77%
- Shares outstanding
- 22.87M
- Short % of float
- 9.76%
- 50-day average
- 81.23
- 200-day average
- 94.49
Analyst view
Consensus: buy
- Target (low)
- 81.00
- Target (mean)
- 107.00
- Target (high)
- 132.00
- Strong buy2
- Buy2
- Hold4
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.68625.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.686 | — | — | — |
| Aug 4, 2026 | Jun 30, 2026 | 0.807 | 0.74 | -0.07 | -8.30% |
| May 5, 2026 | Mar 31, 2026 | 0.66 | 0.68 | +0.02 | +3.03% |
| Feb 25, 2026 | Dec 31, 2025 | 0.67 | 0.68 | +0.01 | +1.49% |
| Nov 6, 2025 | Sep 30, 2025 | 0.564 | 0.62 | +0.06 | +9.93% |
| Aug 5, 2025 | Jun 30, 2025 | 0.57 | 0.60 | +0.03 | +5.26% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 5, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Jun 3, 2026 | Barrington Research | main | Outperform | Outperform |
| May 6, 2026 | Barrington Research | main | Outperform | Outperform |
| May 6, 2026 | Citizens | main | Market Outperform | Market Outperform |
| May 6, 2026 | Wells Fargo | main | Equal-Weight | Equal-Weight |
| Feb 26, 2026 | Barrington Research | main | Outperform | Outperform |
About LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- lemaitre.com
News
- Dividend Income Report: +15.25% And A Listener's Portfolio Roast
- LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026
- LeMaitre Vascular: The Q2 Miss Hides A Stronger Acquisition Machine
- LeMaitre Vascular Data Breach Investigation: Edelson Lechtzin LLP Probes Class Action Claims After Customer Data Is Exposed
- L3Harris Technologies Receives 7-Year, $4.7B Lockheed Martin Contract To Produce Propulsion Systems For PAC-3 Missile Segment Enhancement Interceptor
- PAHC or LMAT: Which Is the Better Value Stock Right Now?
- LeMaitre to Participate at Upcoming Investor Conferences in September
- Dividend Champion, Contender, And Challenger Highlights: Week August 16
- GEHC or LMAT: Which Is the Better Value Stock Right Now?
- LeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut
Your note
Sign in to keep a note on LMAT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| JASINSKI LAWRENCE J | Director | Conversion of Exercise of derivative security | May 6, 2026 | 4,714 |
| KAMKE TRENT G | Officer | Conversion of Exercise of derivative security | Mar 10, 2026 | 6,677 |
| LEBLANC DORIAN PAUL CPA | Chief Financial Officer | Conversion of Exercise of derivative security | Mar 9, 2026 | 2,302 |
| LEMAITRE GEORGE W | Chief Executive Officer | Stock Gift | Jun 3, 2026 | 1,463,420 |
| O'CONNOR JOHN JAMES EDWARD | Director | Conversion of Exercise of derivative security | Feb 25, 2026 | 62,827 |
| PELLEGRINO JOSEPH P JR | Director | Conversion of Exercise of derivative security | Apr 21, 2026 | 15,021 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 14.31% | 3,272,973 | 264.91M | Jun 29, 2026 |
| Conestoga Capital Advisors, LLC | 5.98% | 1,367,513 | 110.69M | Jun 29, 2026 |
| First Trust Advisors LP | 4.78% | 1,093,502 | 88.51M | Jun 29, 2026 |
| Congress Asset Management Co | 4.20% | 961,514 | 77.82M | Sep 29, 2026 |
| Vanguard Capital Management LLC | 4.17% | 953,437 | 77.17M | Jun 29, 2026 |
| Copeland Capital Management, LLC | 4.04% | 924,081 | 74.80M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.53% | 1,265,638 | 102.44M | Sep 29, 2026 |
| First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers | 4.64% | 1,061,703 | 85.93M | Sep 29, 2026 |
| Conestoga Funds-Conestoga Small Cap Fund | 3.80% | 869,016 | 70.34M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.02% | 690,806 | 55.91M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.46% | 563,062 | 45.57M | Sep 29, 2026 |
| Professionally Managed Portfolios-Congress Small Cap Growth Fund | 2.06% | 470,000 | 38.04M | Sep 29, 2026 |